Rapidly progressive crescentic glomerulonephritis: Early treatment is a must.
about
Clinicopathological correlations in lupus nephritis; a single center experience.Green tea polyphenol (-)-epigallocatechin-3-gallate restores Nrf2 activity and ameliorates crescentic glomerulonephritisImproved prognosis in Norwegian patients with glomerulonephritis associated with anti-neutrophil cytoplasmic antibodies.Antineutrophil cytoplasmic antibody-negative pauci-immune glomerulonephritis with massive intestinal bleeding.Clinical Features and Outcomes in Patients With Membranous Nephropathy and Crescent Formation.Parp1 protects against Aag-dependent alkylation-induced nephrotoxicity in a sex-dependent mannerPauci-immune glomerulonephritis in a captive chimpanzee (Pan troglodytes), and a review of spontaneous cases in animals.ANCA-associated vasculitis with renal involvement.Emergency testing for antineutrophil cytoplasmic antibodies combined with a dialog-based policy between clinician and biologist: effectiveness for the diagnosis of ANCA-associated vasculitis.Clinicopathological and long-term prognostic features of membranous nephropathy with crescents: a Japanese single-center experience.Glucocorticoids in the Treatment of Glomerular Diseases: Pitfalls and Pearls.Assessment of the etiologies and renal outcomes of rapidly progressive glomerulonephritis in pediatric patients at King Abdulaziz University Hospital, Jeddah, Saudi Arabia.An inhibitor of spleen tyrosine kinase suppresses experimental crescentic glomerulonephritis.Preserving fertility in an unconscious patient with Goodpasture syndrome-medicolegal and ethical aspectsMethimazole-Induced Pauci-Immune Glomerulonephritis and Anti-Phospholipid Syndrome: An Important Association to Be Aware of
P2860
Q33991334-5E2A72A1-7C3B-4C26-820C-C6FC0DB92B70Q35191850-A75A47B1-CD2E-417B-91BE-93640416968FQ35212086-DB326C84-6FDE-463B-8CAE-55C78B292C4AQ36171183-AA8FAD39-DA38-454D-9CCE-BCB54BB9DE13Q37328402-49F058A9-6C5C-4642-BAC8-E39074AC855DQ37564309-D844534A-3E7A-462E-AD1E-CAD98706C26FQ38923025-25BAD04F-0D60-4029-BBA9-5433FF28B054Q39339897-5AB5C467-A570-449D-8761-6F70D746DAFEQ41958938-121D4C5B-3DA9-43F6-824D-3F417FA02216Q47740261-CB695861-57A0-48B4-9E6A-6BFE6A183C04Q53706807-84BCC13C-736F-4BCC-9DB9-57375F1CE6FCQ54241537-AFDCF377-F548-43C5-913B-8816A18BF104Q55442953-5619BAB3-49D7-45A7-B68A-F3DCD8509776Q56525886-BA772C36-A6DA-4D72-A33F-E51F9C0134B6Q58754779-B2636533-6873-412C-85EA-D643E22499CD
P2860
Rapidly progressive crescentic glomerulonephritis: Early treatment is a must.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Rapidly progressive crescentic glomerulonephritis: Early treatment is a must.
@en
type
label
Rapidly progressive crescentic glomerulonephritis: Early treatment is a must.
@en
prefLabel
Rapidly progressive crescentic glomerulonephritis: Early treatment is a must.
@en
P1433
P1476
Rapidly progressive crescentic glomerulonephritis: Early treatment is a must.
@en
P2093
Claudio Ponticelli
P304
P356
10.1016/J.AUTREV.2014.02.007
P577
2014-03-19T00:00:00Z